The engines have fired up at last for MDX. ( BPRG ) At long last they are being recognised for the force they will become over the next two years. On the cusp of disclosing huge revenue-earning deals with Global pharmacists. These have been hinted at as being unrolled before the years end, but may be in the next days.You still have time to get in at a bargain-basement price before the SP takes off for real shortly.

At what price?

Meldex International confirms potential offer approach received
AFX


LONDON (Thomson Financial) - Meldex International PLC said it has received an approach which may or may not lead to an offer for the company.

A further announcement will be made in due course, the specialty pharma and healthcare company added.

it has to go to min of 120p or i'll be very angry

Saw MDX going up at 1pm ish and bought in more at 59p well happy at selling the lot 2 hours later at 84.5p...wish I could do that every day :-0 I still hold more in my SIPP just in case the offer is higher still.
Di

Hope its for more than when kitso started this thread.

Well Dill somebody wants to buy Meldex, so there must be value after all!! For the record I am still holding, must be a couple of years or so since we had all that fuss about suing Stanelco, who I note now have a fractional share price, not sure what happened after all the ramping but glad I held onto these.

We will have to see what Corporate action now ensues!

Who ever said insider trading was a bad thing.......hush your mouth.

"goldfinger - 29 Dec 2007 03:23 - 18 of 61
Yes a good stratergy to use on this company Dil.

Chart certainly points to 42p and maybe lower. "

Hows the short Going then Goldfinger??

I hope the offer comes through at a higher level, but perhaps caution is required as potential offers can vanish as quickly as they appear. Does this mean MDX will give us the promised trading update or will we have to wait?

Trading update will be issued in January as stated by the company. So not long to wait.

What I'm waiting for now is the SP to drop back to 60's again to buy some more...MDX has proved a brilliant share to buy and sell recently..I've made a packet and I might even be in it when it goes up big time too:-) If it drops back too much I'm out until it rises again. I'm mostly out at the moment after making a pile again yesterday and waiting.
So if it makes it big time, which I hope it does, I make loads if I'm in it at the time but if MDX just goes up and down I still make a mint..Its gotta be good!!
Remember if you can't be good be careful :-)
Di

OOOOOOO back to 60's again ( much quicker than I thought)...now it is time to wait for the turn.
Di

Back in for a few at 66p

Hang on to that knife!

up 2p :-)

3.5p :-)

bought some some MDX at 71p this morning...looking like a serious offer now :-)
Meldex International PLC
16 January 2008


16 January 2008

Meldex International plc

('Meldex' or the 'Company')

Appointment of Adviser

Further to the recent announcement regarding an approach which may or may not
lead to an offer for the Company, the Board of Meldex has appointed Houlihan
Lokey as its financial adviser, effective immediately, to advise it with respect
to its strategic options for the business.

Nomura Code Securities will continue to act as the nominated adviser and broker.

For further information:

Meldex International plc Tel. + 44 (0)20 7098 9880
Richard Trevillion, CEO
Steve Martin, CDO
Hiral Patel, CFO

Houlihan Lokey Tel. + 44 (0)20 7839 3355
Brian McKay
Simon Raynor

Nomura Code Securities Limited Tel. +44 (0)20 7776 1200
Richard Potts
Aasim Qureshi

Corfin Communications Tel. + 44 (0)20 7977 0020
Martin Sutton
Harry Chathli


About Meldex International plc

Meldex International plc is an innovative specialty pharmaceutical and OTC
product company. Listed on London's AIM in May 2003, the Company has over 80
patents granted or in application within 24 patent families and has product
development agreements and strategic alliances with several global healthcare
companies. Meldex has acquired sales and marketing resources within Europe and
the US as a launch mechanism for its own pharmaceutical products. Meldex
acquired the Melbrosin business in June 2007 for a consideration of up to 35m.
Melbrosin's focus is on consumer over the counter health care products based on
substances of natural and plant origin which are developed into consumer
orientated brands and then scaled, produced and distributed by Melbrosin. The
Melbrosin business complements the prescription pharmaceutical sales and
marketing business created and expanded in 2006.

The business continues to develop innovative delivery mechanisms enhancing both
its own product range and those of selected partners using its proprietary
XGELTM polymer technology. For further information please go to

www.meldexinternational.com


About Houlihan Lokey

Houlihan Lokey, an international investment bank, provides a wide range of
services, including mergers and acquisitions ('M&A'), financing and certain
other financial advisory services. In 2006, Houlihan Lokey ranked as the No.1
M&A adviser for U.S. transactions under $1 billion, according to Thomson
Financial. Established in 1970, the firm has 800 employees in 13 offices in the
United States, Europe and Asia. It annually serves more than 1,000 clients
ranging from closely held companies to Global 500 corporations. For more
information, visit
www.HL.com

same here 1 lot this morning and another after the news - this is gonna double from here and more - news will get through to the masses through the press no doubt as its just been seen by those following closely today.

Also we have the trading statement this month - not long to go!

I'm a buyer..topping up!

Who ia ramping this share?

Be careful and try an value the company before you buy!